Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Feeling sick at sea? Learn what to do right away, from alerting the ship's doctor to managing your symptoms and preventing an ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Washington — Much of the federal government shut down Wednesday, October 1, after Congress failed to reach a deal to approve new funding. Republicans had proposed extending government funding at ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, ...

Gucci owner Kering has agreed to sell its beauty business to L'Oreal for 4 billion euros ($4.7 billion), the first major ...

Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...